MRS Meetings and Events

 

SB01.03.21 2023 MRS Spring Meeting

Optimizing the Scale-Up Production of the Biocementing Bacterium Sporosarcina pasteurii

When and Where

Apr 13, 2023
5:00pm - 7:00pm

Moscone West, Level 1, Exhibit Hall

Presenter

Co-Author(s)

Adriana Joson1,2,Michael Carter1,2,Joshua Mancini1,2,Karen Holley1,2,Matthew Tuttle1,2,Rhett Martineau1,Chia-Suei Hung1,Maneesh Gupta1

AFRL1,UES, Inc.2

Abstract

Adriana Joson1,2,Michael Carter1,2,Joshua Mancini1,2,Karen Holley1,2,Matthew Tuttle1,2,Rhett Martineau1,Chia-Suei Hung1,Maneesh Gupta1

AFRL1,UES, Inc.2
Cement is one of the most consumed materials globally, second only to water. The production and maintenance of cement is unsustainable, costly, and a major contributor to greenhouse gas emissions. As urbanization and cement consumption continue to increase, the need to identify a sustainable, comparable, and environmentally friendly alternative becomes increasingly evident. Biocement is a sustainable biomaterial with properties similar to traditional cement. This technology relies on the CaCO3 production resulting from the growth and enzymatic activity of Sporosarcina pasteurii, a bacterium known for its capability of microbially induced calcite precipitation (MICP). The process exploits urease enzymes to catalyze a reaction that produces the ideal basic environment for this alkaliphile to thrive and drive CaCO3 formation. While the process of biocementation is still in its genesis, optimization of biocementation begins with optimizing production of the bacteria responsible for this technology. Here, we propose the optimization of large scale industrial growth through the use of 10 liter bioreactors to serve as a transitional step. By implementing and modifying specific growth parameters, we are able to monitor specific idiosyncrasies of S. pasteurii to produce the largest biomass yields in the shortest time possible, all while maintaining cementation (MICP) efficacy. To curb toxic ammonia production, we decreased the urea concentration that was recommended in previous literature, resulting in a 90% reduction of the produced ammonia with nominal effects to growth rate or cementation efficacy. Even in the absence of urea, bacterial growth is robust, so long as the environment is basic (9.5 pH), with the only detriment being an increase in lag time. With these basic parameters in mind, we were able to evaluate growth in alternative media. These low cost production techniques will further provide the building blocks for this contemporary technology and pave the way for a green and economically feasible alternative construction material.

Keywords

biological | biomaterial

Symposium Organizers

Marie-Eve Aubin-Tam, TU Delft
Maneesh Gupta, U.S. Air Force Research Laboratory
Srikanth Singamaneni, Washington University
Taylor Ware, Texas A&M University

Session Chairs

Marie-Eve Aubin-Tam
Srikanth Singamaneni

In this Session

SB01.03.02
Tissue-Attachable Intestinal Organoids as Injectable Therapeutics for Reconstruction of Intestinal Injuries

SB01.03.03
Tissue Extracellular Matrix-based Microribbon Scaffolds for Bone Regeneration via Immunomodulation

SB01.03.04
Sensory Artificial Octopus Suckers with Highly Adaptive Soft Micro-Denticles

SB01.03.05
Graphically-Encoded Biodegradable Microspheres with Hydrogel Shell for Sustained Release of Drugs at Controlled Rates

SB01.03.06
Nutrient Transport for Increasing the Active Lifespan of Engineered Living Materials

SB01.03.09
Enhancing Microbially-Induced Calcite Precipitation (MICP) Using Protein and Peptide Additives

SB01.03.10
Controlling Shape Morphing and Cell Release in Engineered Living Materials

SB01.03.11
Manufacturing a Three-Dimensional Bioprinted and Oriented Electrospinning Dual-Scale Scaffold to Promote Cellular Alignment and Enhance Structural Elasticity for Muscular Functioning

SB01.03.12
3D Bioprinting Human Blood Vessel Using a Collagen Bioink to Optimize Growth Conditions of Two Primary Cell Lines of HUVEC and HASMC

SB01.03.15
Engineered Extracellular Vesicles for Safe and Efficient Chemo-Sonodynamic Cancer Therapy via Stimuli-Responsive Drug Release

View More »

Publishing Alliance

MRS publishes with Springer Nature